STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. (2023). Research Focus International Scientific Journal, 2(1), 11-19. https://doi.org/10.66073/researchfocus.v2i1.2819